Using the output of the UW workflow, we computed ECD (
Equation 4), CV (
Equation 5), %Guttae (
Equation 6), APL (
Equation 7), and equivalent diameter of the endothelial cells (
Equation 8). The computed ECD and CV values agree with estimates provided by SM and manual segmentation.
Figures 6 and
7 provide a Bland-Altman analysis for comparison of ECD estimates by different methods. In healthy subjects, ECD by Tomey's SM software ranged from 1700 to 3400 cells/mm
2 with an IQR of 2627–2932 cells/mm
2 (n = 31 patients, 60 images). As shown in
Figures 6A to
6C, there is an excellent agreement between different ECD estimates. This is confirmed by one-way ANOVA, as shown in
Figure 6D (
P > 0.38 for the different comparisons). Similar to healthy subjects, we report different ECD estimates from FECD patients in
Figure 7. ECD varied relatively widely with 600 to 3000 cells/mm
2 with an IQR of 2058 to 2818 cells/mm
2 (n = 27 patients, 52 images), unlike in the healthy subjects. Nonetheless, the ECD estimates of the UW approach, Tomey's SM software, and manual segmentation are not significantly different from each other (
Fig. 7D;
P > 0.14).
The size distributions (based on equivalent diameter) were Gaussian in both the healthy and FECD. The distribution was relatively narrow in the healthy (29.66 ± 6.83 µm; IQR: 25.07–33.55 µm) compared to that in the FECD (29.95 µm ± 9.53 µm; IQR: 23.67–34.81 µm) as shown in
Figure 8A. Because ECD declines more rapidly with FECD, polymegathism and pleomorphism would be pronounced during the disease. More importantly, from the perspective of the barrier function of the endothelium, APL increased by ∼300% in the FECD (compared to the mean APL in the healthy). It was 66.87 ± 7.68 µm/cell with an IQR: 61.87–70.79 µm/cell in the healthy (n = 70 patients, 125 images) but it was much higher in the FECD (87.87 ± 26.06 µm/cell; IQR: 69.21–101.1 µm/cell, n = 60 patients, 121 images) as shown in
Figure 8B (
P < 0.0001).
Figure 9 shows variations in ECD and APL with the severity of FECD. In particular, APL in the FECD increased with %Guttae (
Fig. 9A), but the increase is not apparent until %Guttae reaches ∼5%. On the other hand, ECD in the FECD appears to decline with %Guttae from early stages (i.e., even before 5% guttae;
Fig. 9B).